堅瑞沃能(300116.SZ):大股東郭鴻寶所持195.96萬股拍賣成交
格隆匯7月3日丨堅瑞沃能(300116.SZ)公佈,今日,公司通過網絡自查發現,大股東郭鴻寶持有的公司195.9624萬股無限售流通股已通過網絡競價成交。競買人為江建林,拍賣成交價約為人民幣275.22萬元。
截至公告日,郭鴻寶持有公司股份2.7313億股,佔公司總股本的6.38%,其控制下的堅瑞新能源持有公司股份3.0303億股,佔公司總股本的7.08%,郭鴻寶及其一致行動人堅瑞新能源合計持有的股份數佔公司總股本的13.46%。目前,郭鴻寶持有公司股份均已被司法凍結,其控制下的堅瑞新能源持有公司3.0299億股股份被司法凍結。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.